Docket #: S02-234
Deriving Pure Compositions of Mammalian Megakaryocyte Progenitor Cells
Please see issued patent and publication, below, for details.
Publications
Patents
- Published Application: 20050176142
Similar Technologies
-
Lymphodepletion by Selective Apoptosis Induction in T Cells for Safe and Effective Immune Tolerance in Immunotherapy, Transplantation, and Autoimmunity S22-458Lymphodepletion by Selective Apoptosis Induction in T Cells for Safe and Effective Immune Tolerance in Immunotherapy, Transplantation, and Autoimmunity
-
Novel NR1 ES-derived neural stem cell therapy for restoration of neurologic function following ischemic stroke S20-101Novel NR1 ES-derived neural stem cell therapy for restoration of neurologic function following ischemic stroke
-
Cross-reactive antibodies targeting NKp46 that enhance cytotoxicity and proliferation in both human and murine NK cells S23-217Cross-reactive antibodies targeting NKp46 that enhance cytotoxicity and proliferation in both human and murine NK cells